October 9, 2007 - Luna Innovations Inc. has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corp. (Terumo CVS), in which Luna and Terumo CVS will market Luna’s EDAC (Emboli Detection and Classification) Quantifier, as part of Luna's strategy to expand its presence in the U.S.
Luna’s EDAC Quantifier is the only full featured, standalone emboli detection system to receive clearance from the FDA on the market. This cardiopulmonary instrument is uses quantitative ultrasound technology to noninvasively detect gaseous emboli in up to three extracorporeal bypass circuit lines. It reportedly provides repeatable measurement of gaseous emboli.
Although the dynamic quantification of micro gaseous emboli during cardiopulmonary bypass surgery is not presently the global standard of care, Luna hopes that acceptance and widespread adoption of the EDAC will become a standard of care.
For more information: www.lunamedicalproducts.com